ArticleFrontiers in surgery2025
Unilateral biportal endoscopic lumbar interbody fusion vs. posterior lumbar interbody fusion for the treatment of bilateral lumbar spinal stenosis.
Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Unilateral biportal endoscopic transforaminal lumbar interbody fusion versus minimally invasive transforaminal lumbar interbody fusion for single-level lumbar spondylolisthesis: a systematic review and meta-analysis.Frontiers in medicine · 2025Pooled it
- Clinical and Radiological Outcomes of Double-Cage Full Endoscopic Transforaminal Lumbar Interbody Fusion Compared with Posterior Lumbar Interbody Fusion : A Retrospective Cohort Study.Journal of Korean Neurosurgical Society · 2026Article
- Navigation-assisted vs robot -assisted unilateral biportal endoscopic lumbar interbody fusion for single-level lumbar degenerative disease: a retrospective comparative study.Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques · 2026Article
- A Review of Synthetic Bone Grafts in Lumbar Interbody Fusion.Bioengineering (Basel, Switzerland) · 2026Review
- Advancements in unilateral biportal endoscopic lumbar interbody fusion: a narrative review.European journal of medical research · 2026Review
- Early experience with a rapid navigation system-assisted unilateral biportal endoscopic interbody fusion for lumbar spondylolisthesis.Frontiers in surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to evaluate the clinical efficacy and safety of unilateral biportal endoscopic lumbar interbody fusion (UBE-LIF) and posterior lumbar interbody fusion (PLIF) for treating patients with lumbar spinal stenosis with bilateral radiating symptoms. All the patients included in the study had single-segment lumbar spinal stenosis. Methods: From January 2021 to June 2023, 21 patients with lumbar spinal stenosis treated with UBE-LIF and 29 patients with lumbar spinal stenosis treated with PLIF were retrospectively analyzed. Clinical differences in demographic characteristics, surgical details, preoperative and postoperative visual analog scale (VAS) scores, Oswestry Disability Index (ODI) score, MacNab criteria, and complications were analyzed. Results: A total of 50 patients were included in this study. There were no differences in demographic characteristics and MacNab criteria between the two groups ( Conclusions: UBE-LIF was able to achieve the same bilateral decompression as PLIF and resulted in better symptomatic improvement in the early postoperative period, which may be related to it resulting in less damage to the back muscle tissue. This study suggests that UBE-LIF may be a minimally invasive alternative to PLIF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.